It is important to mention that, for the treatment of RASopathy, MEK inhibition is not applied as a cytotoxic therapy with the aim to kill cells, but rather as a mean to bring RAS/MAPK signaling down to normal levels and restore regular cell functions (51). This evidence concerns the gene MAP2K7 and RASopathy.